Study Of SU011248 In Combination With Paclitaxel In Patients With Metastatic Breast Cancer
Status:
Completed
Trial end date:
2007-08-01
Target enrollment:
Participant gender:
Summary
This study is to evaluate the safety of SU011248 in combination with paclitaxel in patients
with metastatic or locally recurrent breast cancer who have not received chemotherapy
treatment in the advanced disease setting.